Pseudoangiosarcoma and cutaneous collagenous vasculopathy in a patient on a Bruton's tyrosine kinase inhibitor

JAAD Case Rep. 2024 Jul 1:51:17-21. doi: 10.1016/j.jdcr.2024.06.011. eCollection 2024 Sep.
No abstract available

Keywords: BTKi; Bruton’s tyrosine kinase inhibitor; CCV; angiosarcoma; cutaneous collagenous vasculopathy.

Publication types

  • Case Reports